Neurocrine Biosciences, Inc. ( NBIX) - Stock Earnings
NBIX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026, midnight | — / — | — | — / — | — |
NBIX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 153.7 million USD | 805.5 million USD |
| 2026Q1 | 197.9 million USD | 814.5 million USD |
| 2026Q2 | 144.4 million USD | 959.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NBIX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 249.7 million USD | 1.9 billion USD |
| 2024 | 341.3 million USD | 2.4 billion USD |
| 2025 | 478.6 million USD | 2.9 billion USD |
| 2026 Est. | — | — |
NBIX
Price: $142.44
Earnings Per Share: 6.65 USD
P/E Ratio: 24.29
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 490000
Ebitda: 15.0 millionMarket Capitalization: 14.5 billion